腹壁瘢痕對(duì)高強(qiáng)度聚焦超聲治療子宮腺肌病的影響
本文選題:高強(qiáng)度聚焦超聲 + 子宮腺肌病 ; 參考:《重慶醫(yī)科大學(xué)》2014年碩士論文
【摘要】:目的:通過比較高強(qiáng)度聚焦超聲治療腹壁有瘢痕與無瘢痕子宮腺肌病患者的治療效果以及不良反應(yīng),評(píng)價(jià)腹壁瘢痕對(duì)HIFU治療子宮腺肌病有效性及安全性的影響。 方法:回顧性分析2011年1月至2014年3月四川省遂寧市中心醫(yī)院534例HIFU治療的子宮腺肌病患者臨床數(shù)據(jù)。其中腹壁有瘢痕組118例,腹壁無瘢痕組416例。通過術(shù)前、術(shù)后超聲造影,比較兩組患者HIFU治療效果。根據(jù)兩組患者治療中、治療后不良反應(yīng)的發(fā)生率,評(píng)價(jià)腹壁瘢痕對(duì)HIFU治療子宮腺肌病安全性的影響。 結(jié)果:(1)本研究發(fā)現(xiàn)腹壁有瘢痕組與無瘢痕組患者的平均消融率及平均輻照劑量均無統(tǒng)計(jì)學(xué)差異(P0.05)。(2)腹壁有瘢痕組與無瘢痕組HIFU術(shù)中不良反應(yīng)的發(fā)生率無統(tǒng)計(jì)學(xué)差異(P0.05);術(shù)后皮膚損傷的發(fā)生率有顯著差異(P0.05)。 結(jié)論:(1)腹壁瘢痕對(duì)HIFU治療子宮腺肌病的有效性無明顯影響。(2)腹壁瘢痕可能導(dǎo)致個(gè)別患者HIFU治療后皮膚損傷,,但通過積極對(duì)癥處理,皮膚損傷預(yù)后良好,無嚴(yán)重不良后果。因此,HIFU治療有腹壁瘢痕的子宮腺肌病是安全的。
[Abstract]:Objective: to evaluate the efficacy and safety of HIFU in the treatment of adenomyosis of uterus with and without scar by high intensity focused ultrasound (HIFU). Methods: the clinical data of 534 patients with adenomyosis treated with HIFU from January 2011 to March 2014 were analyzed retrospectively. There were 118 cases with scar on abdominal wall and 416 cases with no scar on abdominal wall. The effect of HIFU was compared between the two groups by contrast-enhanced ultrasonography before and after operation. To evaluate the effect of abdominal scar on the safety of HIFU in the treatment of adenomyosis. Results in this study, there was no significant difference in the average ablation rate and the average irradiation dose between the scar group and the scar free group. (P < 0.05) there was no significant difference in the incidence of adverse reactions during HIFU operation between the scar group and the scar free group. There was significant difference in the incidence of skin injury after operation. Conclusion (1) abdominal scar has no significant effect on the efficacy of HIFU in the treatment of adenomyosis.) the scar of abdominal wall may lead to skin injury after HIFU treatment in individual patients, but the prognosis of skin injury is good and there are no serious adverse consequences. It is safe to treat adenomyosis with abdominal scar by HIFU.
【學(xué)位授予單位】:重慶醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2014
【分類號(hào)】:R711.71
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 林召;黨小軍;;血清CA125聯(lián)合經(jīng)陰道超聲檢查在子宮腺肌病與子宮肌瘤鑒別診斷中的應(yīng)用[J];國際檢驗(yàn)醫(yī)學(xué)雜志;2011年12期
2 熊小娟;歐陽光;張瑩;賴志文;涂琴;;超聲造影評(píng)價(jià)聚焦超聲在治療子宮肌瘤及腺肌病補(bǔ)充治療中的應(yīng)用[J];重慶醫(yī)學(xué);2013年35期
3 艾志剛;楊彥粉;管潔;;子宮動(dòng)脈栓塞治療子宮腺肌病80例療效分析[J];介入放射學(xué)雜志;2010年04期
4 吳國平;鄒冬芳;;超聲引導(dǎo)下射頻消融治療月經(jīng)過多臨床療效研究[J];臨床軍醫(yī)雜志;2011年03期
5 韓冬;王自能;;子宮腺肌病發(fā)病機(jī)制研究進(jìn)展[J];實(shí)用醫(yī)學(xué)雜志;2010年22期
6 沙阿代提·吾甫爾;再努爾·阿布都熱衣木;古麗娜·阿巴拜克力;;超聲引導(dǎo)下射頻消融治療子宮腺肌病29例臨床分析[J];實(shí)用婦產(chǎn)科雜志;2013年06期
7 涂靈;曹華斌;鄔歡歡;;LNG-IUS與GnRHa方案治療子宮腺肌病效果比較[J];山東醫(yī)藥;2012年30期
8 林瑤琴;羅岳西;;曼月樂治療子宮腺肌癥的臨床療效觀察[J];西部醫(yī)學(xué);2011年07期
9 齊紅燕;;孕三烯酮治療子宮腺肌病51例臨床分析[J];中國婦幼保健;2009年06期
10 劉玉紅;;子宮腺肌癥的MRI表現(xiàn)及診斷價(jià)值[J];現(xiàn)代診斷與治療;2012年07期
本文編號(hào):1775179
本文鏈接:http://sikaile.net/yixuelunwen/fuchankeerkelunwen/1775179.html